Biological drugs in inflammatory bowel disease : Management and care
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:107 |
|---|---|
| Enthalten in: |
Revista espanola de enfermedades digestivas - 107(2015), 7 vom: 03. Juli, Seite 454 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Biological drugs in inflammatory bowel disease: Management and care |
|---|
| Beteiligte Personen: |
Guerra, Iván [VerfasserIn] |
|---|
| Themen: |
91X1KLU43E |
|---|
| Anmerkungen: |
Date Completed 13.12.2016 Date Revised 30.12.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM250568306 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM250568306 | ||
| 003 | DE-627 | ||
| 005 | 20231224160107.0 | ||
| 007 | tu | ||
| 008 | 231224s2015 xx ||||| 00| ||spa c | ||
| 028 | 5 | 2 | |a pubmed24n0835.xml |
| 035 | |a (DE-627)NLM250568306 | ||
| 035 | |a (NLM)26140643 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Guerra, Iván |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biological drugs in inflammatory bowel disease |b Management and care |
| 246 | 3 | 3 | |a Biological drugs in inflammatory bowel disease: Management and care |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 13.12.2016 | ||
| 500 | |a Date Revised 30.12.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Patient Education Handout | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Biological Factors |2 NLM | |
| 650 | 7 | |a Gastrointestinal Agents |2 NLM | |
| 650 | 7 | |a golimumab |2 NLM | |
| 650 | 7 | |a 91X1KLU43E |2 NLM | |
| 650 | 7 | |a Infliximab |2 NLM | |
| 650 | 7 | |a B72HH48FLU |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 700 | 1 | |a Bermejo, Fernando |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de enfermedades digestivas |d 1993 |g 107(2015), 7 vom: 03. Juli, Seite 454 |w (DE-627)NLM012635049 |x 1130-0108 |7 nnns |
| 773 | 1 | 8 | |g volume:107 |g year:2015 |g number:7 |g day:03 |g month:07 |g pages:454 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 107 |j 2015 |e 7 |b 03 |c 07 |h 454 | ||